Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › CA › DUARTE › CITY OF HOPE MEDICAL FOUNDATION

CITY OF HOPE MEDICAL FOUNDATION

NPI: 1871886366 · DUARTE, CA 91010 · Anesthesiology Physician · NPI assigned 05/17/2011

$40.53M
Total Medicaid Paid
728,218
Total Claims
499,048
Beneficiaries
185
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialJENSEN, VINCE (CHIEF EXECUTIVE)
NPI Enumeration Date05/17/2011

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 74,245 $3.34M
2019 81,536 $4.50M
2020 90,785 $4.62M
2021 102,066 $5.65M
2022 106,116 $5.88M
2023 136,074 $8.68M
2024 137,396 $7.85M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 126,958 109,269 $5.44M
G6015 Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session 26,774 3,416 $4.65M
J9271 Injection, pembrolizumab, 1 mg 637 518 $3.01M
99215 Prolong outpt/office vis 41,609 32,375 $2.23M
77014 46,303 6,722 $1.92M
99233 Prolong inpt eval add15 m 42,567 9,933 $1.91M
99232 Subsequent hospital care, per day, moderate complexity 48,519 13,162 $1.64M
J0897 Injection, denosumab, 1 mg 1,738 1,697 $1.34M
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 49,041 46,478 $1.27M
78815 Positron emission tomography (PET) for limited area imaging 6,495 6,377 $1.25M
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance 16,827 10,985 $956K
77427 10,179 4,892 $746K
77301 1,317 1,273 $724K
99223 Prolong inpt eval add15 m 8,071 7,238 $677K
88305 Level IV - Surgical pathology, gross and microscopic examination 15,739 14,748 $665K
J2506 Injection, pegfilgrastim, excludes biosimilar, 0.5 mg 473 378 $599K
G6012 Radiation treatment delivery, 3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 6-10 mev 4,430 724 $528K
J2505 Injection, pegfilgrastim, 6 mg 218 162 $476K
J9144 Injection, daratumumab, 10 mg and hyaluronidase-fihj 64 38 $427K
77334 4,602 3,585 $411K
74178 8,030 7,878 $407K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences 6,353 6,039 $405K
99205 Prolong outpt/office vis 5,845 5,561 $378K
Q5117 Injection, trastuzumab-anns, biosimilar, (kanjinti), 10 mg 384 265 $355K
71260 Computed tomography, thorax, diagnostic; with contrast material 14,382 13,844 $347K
77338 2,113 1,960 $347K
96375 Therapeutic injection; each additional sequential IV push 11,046 7,204 $343K
J0185 Injection, aprepitant, 1 mg 1,849 1,329 $336K
99204 Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 5,773 5,650 $328K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 8,211 6,161 $274K
88342 8,319 7,786 $271K
77263 2,868 2,802 $263K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 5,613 5,518 $239K
77300 3,184 2,879 $234K
J1439 Injection, ferric carboxymaltose, 1 mg 679 475 $232K
J9299 Injection, nivolumab, 1 mg 84 53 $227K
77336 6,542 3,047 $226K
99222 Initial hospital care, per day, moderate complexity 3,746 3,180 $195K
88341 4,347 4,049 $173K
Q5107 Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg 266 122 $158K
G0452 Molecular pathology procedure; physician interpretation and report 7,146 6,297 $157K
G6002 Stereoscopic x-ray guidance for localization of target volume for the delivery of radiation therapy 4,988 717 $156K
77295 669 629 $149K
88189 2,397 2,169 $140K
88108 7,883 6,638 $134K
88321 3,354 3,210 $134K
93010 Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only 18,078 15,199 $129K
76641 5,144 3,677 $121K
Q5111 Injection, pegfilgrastim-cbqv (udenyca), biosimilar, 0.5 mg 53 39 $116K
77290 1,422 1,262 $110K
85097 3,195 3,113 $100K
J2469 Injection, palonosetron hcl, 25 mcg 1,600 1,039 $100K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 3,244 2,462 $99K
88307 1,262 1,224 $98K
74177 Computed tomography, abdomen and pelvis; with contrast material 2,146 2,124 $96K
99231 Subsequent hospital care, per day, straightforward or low complexity 5,532 2,178 $95K
J9035 Injection, bevacizumab, 10 mg 76 36 $94K
96417 3,396 2,375 $91K
J2405 Injection, ondansetron hydrochloride, per 1 mg 3,901 2,369 $85K
88360 1,461 1,369 $78K
96367 2,275 1,665 $68K
99442 2,089 1,995 $68K
G6017 Intra-fraction localization and tracking of target or patient motion during delivery of radiation therapy (eg,3d positional tracking, gating, 3d surface tracking), each fraction of treatment 126 12 $63K
96450 541 416 $63K
36522 111 51 $57K
71045 Radiologic examination, chest; single view 10,584 7,141 $56K
99152 2,870 2,768 $49K
77470 697 678 $47K
99221 1,385 1,237 $44K
38222 657 593 $43K
96415 2,095 1,591 $43K
71250 2,032 1,918 $40K
99203 Office or other outpatient visit for the evaluation and management of a new patient, low complexity 1,292 1,282 $39K
77280 1,001 891 $38K
85060 2,627 2,491 $35K
74183 756 752 $34K
99443 1,016 956 $34K
J9217 Leuprolide acetate (for depot suspension), 7.5 mg 137 135 $31K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 1,132 1,094 $30K
52000 804 802 $30K
71046 Radiologic examination, chest; 2 views 4,832 4,148 $30K
96401 198 113 $29K
88381 582 556 $28K
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) 1,761 1,580 $27K
93356 1,280 1,266 $25K
99255 238 230 $22K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 1,359 602 $21K
77065 Tomosynthesis, mammo 1,032 992 $21K
96402 747 717 $18K
99497 392 365 $18K
88311 2,936 2,858 $17K
77066 Tomosynthesis, mammo 710 691 $17K
G2012 Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion 1,600 1,555 $17K
99239 Hospital discharge day management, more than 30 minutes 391 350 $16K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes 155 61 $16K
84165 5,598 5,208 $15K
94727 1,655 1,629 $15K
93307 536 535 $15K
99441 692 679 $14K
J9395 Injection, fulvestrant, 25 mg 154 143 $14K
G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) 1,347 1,337 $13K
99417 Prolong home eval add 15m 213 207 $13K
J0640 Injection, leucovorin calcium, per 50 mg 509 215 $13K
94729 2,047 2,015 $12K
J9202 Goserelin acetate implant, per 3.6 mg 27 24 $12K
96361 Intravenous infusion, hydration; each additional hour 1,671 743 $11K
94010 1,307 1,292 $10K
72197 233 232 $10K
J9267 Injection, paclitaxel, 1 mg 466 225 $10K
78816 65 65 $10K
51798 638 601 $10K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple 145 145 $10K
77003 577 446 $10K
96377 374 276 $9K
96411 357 266 $9K
86334 2,096 1,968 $9K
J1100 Injection, dexamethasone sodium phosphate, 1 mg 4,173 2,382 $8K
88188 143 134 $8K
78306 435 431 $7K
77049 97 97 $7K
70491 256 251 $7K
G0498 Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted living) using a portable pump provided by the office/clinic, includes follow up office/clinic visit at the conclusion of the infusion 116 77 $7K
96523 450 374 $7K
76937 719 681 $6K
J1453 Injection, fosaprepitant, 1 mg 32 14 $6K
51701 191 186 $6K
88333 132 129 $6K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour 502 353 $5K
88312 245 225 $5K
77001 510 498 $5K
J1200 Injection, diphenhydramine hcl, up to 50 mg 4,020 2,690 $5K
70450 Computed tomography, head or brain; without contrast material 226 198 $4K
J9190 Injection, fluorouracil, 500 mg 824 341 $4K
88313 132 127 $4K
36561 25 25 $4K
96368 276 186 $4K
76536 304 304 $3K
74176 Computed tomography, abdomen and pelvis; without contrast material 124 117 $3K
Q5106 Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units 31 13 $3K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 899 632 $3K
J9045 Injection, carboplatin, 50 mg 222 159 $3K
77080 448 389 $3K
77067 Screening mammography, bilateral, including computer-aided detection 62 62 $3K
36591 283 200 $2K
88173 51 51 $2K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 129 109 $2K
31575 39 38 $2K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete 107 106 $2K
J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units 40 27 $2K
00731 55 52 $2K
76705 Ultrasound, abdominal, real time with image documentation; limited 108 102 $1K
94060 127 126 $1K
J3490 Unclassified drugs 2,113 1,290 $1K
93970 79 70 $1K
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg 843 758 $1K
77063 Screening digital breast tomosynthesis, bilateral 62 62 $1K
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program 4,590 3,182 $1K
76830 Ultrasound, transvaginal 67 67 $1K
76942 92 90 $1K
99386 19 19 $1K
72158 18 15 $841.67
J9263 Injection, oxaliplatin, 0.5 mg 54 24 $820.95
J7030 Infusion, normal saline solution , 1000 cc 866 369 $759.54
94726 86 86 $738.56
76642 17 16 $711.78
99238 Hospital discharge day management, 30 minutes or less 28 26 $656.28
88309 12 12 $622.64
51702 13 13 $579.88
36620 24 24 $531.22
71020 65 37 $529.50
01992 12 12 $514.83
J3489 Injection, zoledronic acid, 1 mg 14 13 $484.88
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward 27 26 $463.82
00811 20 12 $412.53
77417 29 14 $364.79
95251 12 12 $312.03
G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or qualified healthcare professional, with or without direct patient contact (list separately in addition to cpt codes 99205, 99215, 99483 for office or other outpatient evaluation and management services) (do not report g2212 on the same date of service as 99358, 99359, 99415, 99416). (do not report g2212 for any time unit less than 15 minutes) 27 27 $296.16
74018 49 39 $285.63
74420 29 27 $280.10
J1720 Injection, hydrocortisone sodium succinate, up to 100 mg 33 25 $219.52
71010 27 25 $172.94
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 29 29 $153.41
93971 13 13 $145.03
86320 15 15 $110.09
88300 12 12 $11.89